FDA Limits J&J’s COVID-19 Vaccine Over Blood Clot Risk Friday, May 6, 2022 By Stillness in the Storm Leave a Comment (Tyler Durden) The Food and Drug Administration (FDA) on Thursday strictly limited who can receive Johnson & Johnson’s Covid-19 vaccine due to a rare but serious risk of blood clots.